ISLAMABAD: The federal cabinet has approved reduction in maximum retail price (MRP) of originator brands of above 59 products by up to 10 percent, Drug Regulatory Authority of Pakistan (DRAP) said in a statement on Thursday.
DRAP spokesperson said the federal government has introduced a transparent way through the Drug Pricing Policy-2015 for price increase as well as decrease of MRP of medicines. The policy was notified after the approval of the DRAP policy board, the economic Coordination Committee (ECC) of the cabinet and the federal government.
The spokesperson said the impression that DRAP only works on increasing prices is wrong, “DRAP has reduced the prices of a number of brands having high sales volume”.
Under the provisions of the said policy, on the recommendation of the authority, the federal cabinet has approved reduction in MPR of originator brands of above 59 products up to 10 percent.
Chinese power company had intended to acquire up to 18.336 billion ordinary shares of K-Electric, representing 66.4...
MARI also successfully drilled and tested another appraisal well in the Mari Ghazij formation located in Mari D&PL
Gold rates decreased by $30 to $2,381 per ounce in the international market
Growing number of Americans have seen their savings dwindle as rising prices squeeze budgets while interest rates stay...
IMF will closely watch the privatization of PIA by the end of June
PSX lays down the groundwork to encourage listed companies to adopt ESG reporting in line with global standards
